|
Sep 6
|
Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research
|
|
Sep 5
|
Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Sep 5
|
Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?
|
|
Sep 4
|
Why Is Axsome (AXSM) Up 4.8% Since Last Earnings Report?
|
|
Jul 30
|
BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
|
|
Jul 30
|
Pfizer (PFE) Beats on Q2 Earnings & Sales, Raises 2024 View
|
|
Jul 30
|
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
|
|
Jul 29
|
Company News for Jul 29, 2024
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 29
|
Bristol Myers Squibb reports dip in net income for Q2 2024
|
|
Jul 27
|
Why Wall Street is unfazed by Medicare drug pricing threat
|
|
Jul 27
|
2 High-Yield Dividend Stocks That Could Shine in 2025
|
|
Jul 27
|
Q2 2024 Bristol-Myers Squibb Co Earnings Call
|
|
Jul 26
|
Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win
|
|
Jul 26
|
These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
|
|
Jul 26
|
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
|
|
Jul 26
|
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
|
|
Jul 26
|
Newell Brands, 3M rise; Saia, DexCom fall, Friday, 7/26/2024
|
|
Jul 26
|
Top Midday Stories: Fed's Preferred Inflation Reading Up in June; 3M's Adjusted Earnings Gain; DexCom Cuts 2024 Revenue Guidance; Bristol-Myers Squibb's Higher Results; WesBanco, Premier Financial to Merge
|
|
Jul 26
|
Stocks to Watch Friday: DexCom, 3M, Coinbase, Charter
|